Restricted accessResearch articleFirst published online 2022-11
Identification of Diagnostic Variants in FGFR2 and NPR2 Genes in a Chinese Family Affected by Crouzon Syndrome and Acromesomelic Dysplasia,Type Maroteaux
This study aims to conduct a comprehensive clinical and genetic investigation on a large family with members having various phenotypes, including acromesomelic dysplasia, type Maroteaux (AMDM), idiopathic short stature (ISS), Crouzon syndrome (CS). Prenatal diagnosis was performed on the high-risk fetus. We performed the whole-exome sequencing on three members with AMDM, ISS, or CS. Detailed genotypes and phenotypes were investigated on members of this 4-generation family. Genetic analysis identified three variants, which were designated as p.Val548del, p.Arg989Gln in natriuretic peptide receptor B/guanylate cyclase B (NPR2), and p.Cys342Tyr in fibroblast growth factor receptor-2 (FGFR2). Compound heterozygous variation consisting of p.Val548del and p.Arg989Gln caused AMDM. NPR2 heterozygous variant carriers exhibited normal height or ISS. The p.Cys342Tyr mutation of FGFR2 causes the typical clinical phenotype of CS. The fetus carried the heterozygous p.Val548del and p.Cys342Tyr mutations, with ultrasound results showing exophthalmos, parrot-beaked nose, low and flat frontal skull, and intrauterine growth retardation at the second and third trimesters of gestation. We are reporting those two novel mutations (p.Val548del and p.Arg989Gln) in NPR2 and a p.Cys342Tyr mutation in FGFR2 in an extended Chinese family. This finding extended the genotype–phenotype spectra of ISS, AMDM, and CS related to pathogenic variants.
Get full access to this article
View all access options for this article.
References
1.
Arnaud-LopezL, FragosoR, Mantilla-CapachoJ, et al.Crouzon with acanthosis nigricans. Further delineation of the syndrome. Clin Genet, 2007; 72(5):405–410; doi: 10.1111/j.1399-0004.2007.00884.x
2.
BartelsCF, BukulmezH, PadayattiP, et al.Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet, 2004; 75(1):27–34; doi: 10.1086/422013
3.
CohenMMJr.Let's call it “Crouzonodermoskeletal syndrome” so we won't be prisoners of our own conventional terminology. Am J Med Genet, 1999; 84(1):74; doi: 10.1002/(SICI)1096-8628(19990507)84:1<74::AID-AJMG14>3.0.CO;2-R
4.
CohenMMJr., KreiborgS. Birth prevalence studies of the Crouzon syndrome: Comparison of direct and indirect methods. Clin Genet, 1992; 41(1):12–15; doi: 10.1111/j.1399-0004.1992.tb03620.x
5.
ConradyCD, PatelBC. Crouzon Syndrome. StatPearls: Treasure Island, FL, USA; 2020.
6.
de CarvalhoAA, CarvalhoJA, FigueiredoIJr., Association of midtrimester short femur and short humerus with fetal growth restriction. Prenat Diagn, 2013; 33(2):130–133; doi: 10.1002/pd.4020
7.
EswarakumarVP, HorowitzMC, LocklinR, et al.A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci U S A, 2004; 101(34):12555–12560; doi: 10.1073/pnas.0405031101
8.
FaivreL, Le MerrerM, MegarbaneA, et al.Exclusion of chromosome 9 helps to identify mild variants of acromesomelic dysplasia Maroteaux type. J Med Genet, 2020; 37(1):52–54; doi: 10.1136/jmg.37.1.52
9.
FanJ, LiY, JiaR, FanX. An inherited FGFR2 mutation increased osteogenesis gene expression and result in Crouzon syndrome. BMC Med Genet, 2018; 19(1):91; doi: 10.1186/s12881-018-0607-8
10.
ForteAJ, LuX, HashimPW, et al.Analysis of airway and midface in Crouzon Syndromes. Ann Plast Surg, 2019; 82(6):686–691; doi: 10.1097/SAP.0000000000001740
11.
GlaserRL, JiangW, BoyadjievSA, et al.Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet, 2000; 66(3):768–777; doi: 10.1086/302831
HanleyPC, KanwarHS, MartineauC, et al.Short stature is progressive in patients with heterozygous NPR2 mutations. J Clin Endocrinol Metab, 2020; 105(10):3190–3202; doi: 10.1210/clinem/dgaa491
14.
Hisado-OlivaA, Garre-VazquezAI, Santaolalla-CaballeroF, et al.Heterozygous NPR2 mutations cause disproportionate short stature, similar to Leri-Weill Dyschondrosteosis. J Clin Endocrinol Metab, 2015; 100(8):E1133–E1142; doi: 10.1210/jc.2015-1612
15.
HwangIT, MizunoY, AmanoN, et al.Role of NPR2 mutation in idiopathic short stature: Identification of two novel mutations. Mol Genet Genomic Med, 2020; 8(3):e1146; doi:10.1002/mgg3.1146
16.
Irfanullah, ZebA, ShinwariN, et al.Molecular and in silico analyses validates pathogenicity of homozygous mutations in the NPR2 gene underlying variable phenotypes of Acromesomelic dysplasia, type Maroteaux. Int J Biochem Cell Biol, 2018; 102:76–86; doi: 10.1016/j.biocel.2018.07.004
17.
JeeYH, BaronJ, NilssonO. New developments in the genetic diagnosis of short stature. Curr Opin Pediatr, 2018; 30(4):541–547; doi: 10.1097/MOP.0000000000000653
18.
JelenkovicA, SundR, HurY-M, et al.Genetic and environmental influences on height from infancy to early adulthood: An individual-based pooled analysis of 45 twin cohorts. Sci Rep, 2016; 6:28496; doi: 10.1038/srep28496
19.
KeR, LeiJ, GeM, et al.Severe meningeal calcification in a Crouzon patient carrying a mutant C342W FGFR2. J Craniofac Surg, 2015; 26(2):557–559; doi: 10.1097/SCS.0000000000001393
20.
KeX, LiangH, MiaoH, et al.Clinical characteristics of short-stature patients with an NPR2 mutation and the therapeutic response to rhGH. J Clin Endocrinol Metab, 2021; 106(2):431–441; doi: 10.1210/clinem/dgaa842
21.
KreiborgS, CohenMMJr. Ocular manifestations of Apert and Crouzon syndromes: Qualitative and quantitative findings. J Craniofac Surg, 2010; 21(5):1354–1357; doi: 10.1097/SCS.0b013e3181ef2b53
LiB, YangH, WeiY, et al.Is it time to change our reference curve for femur length? Using the Z-score to select the best chart in a Chinese Population. PLoS One, 2016; 11:e0159733; doi: 10.1371/journal.pone.0159733
24.
LinM, LuY, SuiY, et al.Extremely severe scoliosis, heterotopic ossification, and osteoarthritis in a three-generation family with Crouzon syndrome carrying a mutant c.799T>C FGFR2. Mol Genet Genomic Med, 2019; 7(9):e843; doi: 10.1002/mgg3.843
25.
LinY, GaoH, AiS, et al.FGFR2 mutations and associated clinical observations in two Chinese patients with Crouzon syndrome. Mol Med Rep, 2017; 16(5):5841–5846; doi: 10.3892/mmr.2017.7397
26.
LuX, ForteAJ, WilsonA, et al.Growth patterns of the airway in Crouzon syndrome patients with different types of cranial vault suture synostosis. Int J Oral Maxillofac Surg, 2021; 50(7):924–932; doi: 10.1016/j.ijom.2020.11.023
27.
MarouliE, GraffM, Medina-GomezC, et al.Rare and low-frequency coding variants alter human adult height. Nature, 2017; 542(7640):186–190; doi: 10.1038/nature21039
28.
McKennaA, HannaM, BanksE, et al.The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res, 2010; 20(9):1297–1303; doi: 10.1101/gr.107524.110
29.
MenasheY, Ben BaruchG, RabinovitchO, et al.Exophthalmus—Prenatal ultrasonic features for diagnosis of Crouzon syndrome. Prenat Diagn, 1989; 9(11):805–808; doi: 10.1002/pd.1970091109
30.
MustafaS, AkhtarZ, LatifM, et al.A novel nonsense mutation in NPR2 gene causing Acromesomelic dysplasia, type Maroteaux in a consanguineous family in Southern Punjab (Pakistan). Genes Genomics, 2020; 42(8):847–854; doi: 10.1007/s13258-020-00955-3
31.
OlneyRC, BukulmezH, BartelsCF, et al.Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. J Clin Endocrinol Metab, 2006; 91(4):1229–1232; doi: 10.1210/jc.2005-1949
32.
PerolaM, SammalistoS, HiekkalinnaT, et al.Combined genome scans for body stature in 6,602 European twins: Evidence for common Caucasian loci. PLoS Genet, 2007; 3(6):e97; doi: 10.1371/journal.pgen.0030097
33.
PlachyL, DusatkovaP, MaratovaK, et al.NPR2 variants are frequent among children with familiar short stature and respond well to growth hormone therapy. J Clin Endocrinol Metab, 2020; 105(3):dgaa037; doi: 10.1210/clinem/dgaa037
34.
RichardsS, AzizN, BaleS, et al.Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015; 17(5):405–424; doi: 10.1038/gim.2015.30
35.
RoscioliT, ElakisG, CoxTC, et al.Genotype and clinical care correlations in craniosynostosis: Findings from a cohort of 630 Australian and New Zealand patients. Am J Med Genet C Semin Med Genet, 2013; 163C(4):259–270; doi: 10.1002/ajmg.c.31378
36.
San LucasFA, WangG, ScheetP, et al.Integrated annotation and analysis of genetic variants from next-generation sequencing studies with variant tools. Bioinformatics, 2012; 28(3):421–422; doi: 10.1093/bioinformatics/btr667
37.
Snyder-WarwickAK, PerlynCA, PanJ, et al.Analysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate. Proc Natl Acad Sci U S A, 2010; 107(6):2515–2520; doi: 10.1073/pnas.0913985107
38.
VasquesGA, AmanoN, DockoAJ, et al.Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature. J Clin Endocrinol Metab, 2013; 98(10):E1636–E1644; doi: 10.1210/jc.2013-2142
39.
WangSR, JacobsenCM, CarmichaelH, et al.Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature. Hum Mutat, 2015; 36(4):474–481; doi: 10.1002/humu.22773
YengoL, SidorenkoJ, KemperKE, et al.Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry. Hum Mol Genet, 2018; 27(20):3641–3649; doi: 10.1093/hmg/ddy271
42.
ZhuJJ, QiH, CaiLR, et al.C-banding and AgNOR-staining were still effective complementary methods to indentify chromosomal heteromorphisms and some structural abnormalities in prenatal diagnosis. Mol Cytogenet, 2019; 12:41; doi: 10.1186/s13039-019-0453-1
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
